Spotlight
Video

Lung cancer vaccine MAGE-A3 does not improve disease-free survival in resected lung cancer

EMJ has 458 videos Subscribe Here

Loading........
Description: At ESMO 2014, Prof Johan F. Vansteenkiste summarises the results of the MAGRIT trial, a phase III trial which showed that MAGE-A3 cancer immunotherapy did not increase disease-free survival in patients with resected NSCLC.
Shared By : EMJ
Posted on : 10/03/14
Added : 3 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.